NHS England has urged the pharmacy owners to continue to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority (NHSBSA) for Quarter 4 (Q4) 2022/23 (January to March 2023).
Community Pharmacy England have agreed with NHS England that the quarterly returns will continue to be on a voluntary basis, with Q4 (January to March 2023) as the second quarter to be reported.
It has thanked all the members that submitted NMS quarterly summary data for Quarter 3.
The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic.
“NHS England wants to continue collection of the quarterly returns to provide baseline data to support a long-term evaluation that will be conducted as part of ongoing work to expand the scope of NMS,” said Community Pharmacy England.
Voluntary submissions can be made via the NHSBSA website, where an updated reporting spreadsheet is also available for head offices to use who are able to submit data on behalf of multiple pharmacies.
NHS England, NHSBSA, Community Pharmacy England and IT system suppliers are continuing work on the development of an Application Programming Interface (API) that will enable this transfer of data to be made as part of the service payment claim that will then make the need for these retrospective quarterly returns.
